Current Concepts in Antisense Drug Design

Journal of Medicinal Chemistry

Volumn 36, Issue 14, 1993, Pages 1923-1937

  Milligan, John F ^a   Matteucci, Mark D ^a   Martin, John C ^a  

^a GILEAD SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CARBAMIC ACID; CARBONIC ACID; CD4 ANTIGEN; CYTIDINE DERIVATIVE; DEOXYRIBOSE; ENDONUCLEASE; GAG PROTEIN; GLYCOPROTEIN GP 120; HEXOSE; MESSENGER RNA; METHYLPHOSPHONIC ACID; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; PHOSPHORAMIDIC ACID DERIVATIVE; PHOSPHOROTHIOIC ACID DERIVATIVE; POLYLYSINE; PURINE DERIVATIVE; PYRIMIDINE DERIVATIVE; RNA; THYMIDINE DERIVATIVE; VIRUS T ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CHEMICAL BOND; DRUG DESIGN; DRUG HALF LIFE; DRUG MECHANISM; DRUG PENETRATION; DRUG SPECIFICITY; DRUG STABILITY; DRUG STRUCTURE; DRUG TARGETING; GENE EXPRESSION; GROWTH INHIBITION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; INTRADERMAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; ONCOGENE C MYB; ONCOGENE RAS; PRIORITY JOURNAL; REVIEW; TOPICAL DRUG ADMINISTRATION; VIRUS INFECTION; VIRUS INHIBITION; WART VIRUS;

ANIMAL; DRUG DESIGN; GENE EXPRESSION; HUMAN; OLIGONUCLEOTIDES, ANTISENSE; STRUCTURE-ACTIVITY RELATIONSHIP; VIRUS INHIBITORS; VIRUS REPLICATION;

EID: 0027228277     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00066a001     Document Type: Article

References (167)

1. Weintraub, H. M. Antisense RNA and DNA. Sci. Am. 1990, 262, 40–46.
2. Helene, C.; Toulme, J. Specific Regulation of Gene Expression by Antisense, Sense and Antigene Nucleic Acids. Biochim. Biophys. Acta 1990, 1049, 99–125.
3. Cohen, J. S., Ed. Oligodeoxynucleotides as Antisense Inhibitors of Gene Expression; CRC Press: Boca Raton, FL, 1987.
4. Cohen, J. S. Antisense Oligodeoxynucleotides as Antiviral Agents. Antivir. Res. 1991, 16, 121–133.
5. Stein, C. A.; Tonkinson, J. L.; Yakubov, L. Phosphothioate Oligodeoxynucleotides—Antisense Inhibitors of Gene Expression? Pharmacol. Ther. 1991, 52, 365–384.
6. Bischofberger, N.; Wagner, R. W. Antisense Approaches to Antiviral Agents. Semin. Virol. 1992, 3, 57–66.
7. Tidd, D. M. A Potential Role for Antisense Oligonucleotide Analogues in the Development of Oncogene Targeted Cancer Therapy. Anticancer Res. 1990, 10, 1169–1182.
8. Calabretta, B. Inhibition of Protooncogene Expression by Antisense Oligodeoxynucleotides: Biological and Therapeutic Implications. Cancer Res. 1991, 51, 4505–4510.
9. Morvan, F.; Porumb, H.; Degols, G.; Lefebvre, I.; Pompon, A.; Sproat, B. S.; Rayner, B.; Malvy, C.; Lebleu, B.; Imbach, J.-L. Comparative Evaluation of Seven Oligonucleotide Analogues as Potential Antisense Agents. J. Med. Chem. 1993, 36, 280–287.
10. Bennett, F. C.; Chiang, M. Y.; Chan, H. C.; Shoemaker, J. E. E.; Mirabelli, C. K.; Cationic Lipids Enhance Cellular Uptake and Activity of Phosphorothioate Antisense Oligonucleotides. Mol. Pharm. 1992, 41, 1023–1033.
11. Wagner, R. W.; Matteucci, M. D.; Lewis, J. L.; Gutierrez, A. J.; Moulds, C.; Froehler, B. C. Antisense Gene Inhibition by Oligonucleotides Containing C-5 Propyne Pyrimidines. Science 1993, 260, 1510–1513.
12. Green, P. J.; Pines, O.; Inouye, M. The Role of Antisense RNA and Gene Regulation. Annu. Rev. Biochem. 1986, 55, 569–597.
13. Izant, J. G.; Weintraub, H. Constitutive and Conditional Suppression of Exogenous and Endogenous Genes by Anti-Sense RNA. Science 1985, 229, 345–352.
14. Bass, B. L.; Weintraub, H. An Unwinding Activity that Covalently Modifies its Double-Stranded RNA Substrate. Cell 1988, 55, 1089–1098.
15. Wagner, R. W.; Smith, J. E.; Cooperman, B. S.; Nishikura, K. A Double-Stranded Unwinding Activity Introduces Structural Alterations by Means of Adenosine to Inosine Conversion in Mammalian Cells and Xenopus Eggs. Proc. Natl. Acad. Sci. U.S.A. 1989, 86, 5586–5590.
16. Wagner, R. W.; Yoo, C.; Wrabetz, L.; Bucchalter, J.; Hassan, N. F.; Khalili, K.; Kim, S. U.; Perussia, B.; McMorris, F. A.; Nishikura, K. Double-Stranded Unwinding Activity That is Detected Ubiquitously in Primary Tissue and Cell Lines. Mol. Cell. Biol. 1990, 10, 5586–5590.
17. Zamecnik, P. C.; Stephenson, M. L. Inhibition of Rous Sarcoma Virus Replication and Cell Transformation by a Specific Oligodeoxynucleotide. Proc. Natl. Acad. Sci. U.S.A. 1978, 75, 280–284.
18. Spaapen, L. J. M.; Rijkers, G. T.; Steal, G. E.; Rijksen, G.; Wadman, S. K.; Stoop, J. W.; Zegers, B. J. M. The Effect of Deoxyguanosine on Human Lymphocyte Function: I. Analysis of the Interference with Lymphocyte Proliferation In Vitro. J. Immunol. 1984, 132, 2311–2317.
19. Scharenberg, J. G. M.; Rijkers, G. T.; Toebes, E. A. H.; Steal, G. E. J.; Zegers, B. J. M. Expression of Deoxyadenosine and Deoxyguanosine Toxicity at Different Stages of Lymphocyte Activation. Scand. J. Immunol. 1988, 28, 87–93.
20. Redelman, D.; Bluestein, H. G.; Cohen, A. H.; Depper, J. M.; Wormsley, S. Deoxyadenosine (AdR) Inhibition of Newly Activated Lymphocytes: Blockade at the G0-G1 Interface. J. Immunol. 1984, 132, 2030–2038.
21. Sidi, Y.; Edwards, N. L.; Winkler, C.; Bunn, P.; Mitchell, B. S. Differential Metabolism of Deoxyribonucleosides by Leukaemic T Cells of Immature and Mature Phenotype. Br. J. Haematol. 1985, 61, 125–134.
22. Yaswen, P.; Stampfer, M. R.; Gosh, K. and Cohen, J. Effects of Sequence of Thioated Oligonucleotides on Cultured Human Mammary Epithelial Cells. Antisense Res. Dev. 1993, 3, 67–77.
23. Mayford, M.; Weisblum, B. Conformational Alteration in the ermC Transcript In Vivo During Induction. EMBO J. 1989, 8, 4307–4314.
24. Verspieren, P.; Loreau, N. L.; Thuong, N. T.; Shire, D.; Toulme, J. J. Effect of RNA Secondary Structure and Modified Bases on the Inhibition of Trypanosomid Protein Synthesis in Cell Free Extracts by Antisense Oligodeoxynucleotides. Nucleic Acids Res. 1990, 18, 4711–4717.
25. Lima, W. F.; Monia, B. P.; Ecker, D. J.; Freier, S. M. Implication of RNA Structure on Antisense Oligonucleotide Hybridization Kinetics. Biochemistry 1992, 31, 12055–12061.
26. Stull, R. A.; Taylor, L. A.; Szoka, F. C. Predicting Antisense Oligonucleotide Inhibitory Efficacy: A Computational Approach Using Histograms and Thermodynamic Indices. Nucleic Acids Res. 1992, 20, 3501–3508.
27. Bennett, R. M.; Gabor, G. T.; Merritt, M. M. DNA Binding to Human Leukocytes. J. Clin. Invest. 1985, 12, 2182–2190.
28. Bennett, R. M.; Hefeneider, S. H.; Bakke, A.; Merritt, M.; Smith, C. A.; Mourich, D.; Heinrich, M. C. The Production and Characterization of Murine Monoclonal Antibodies to a DNA Receptor on Human Leukocytes. J. Immun. 1988, 140, 2937–2942.
29. Loke, S. L.; Stein, C. A.; Zhang, X. H.; Mori, K.; Nakanishi, M.; Subasinghe, C.; Cohen, J. S.; Neckers, L. M. Characterization of Oligonucleotide Transport Into Living Cells. Proc. Natl. Acad. Sci. U.SA. 1989, 86, 3474–3478.
30. Ceruzzi, M.; Draper, K.; Schwartz, J. Natural and Phosphorothioate-Modified Oligodeoxyribonucleotides Exhibit a Non-Random Cellular Distribution. Nucleosides Nucleotides 1990, 9, 679–695.
31. Shoji, Y.; Akhtar, S.; Periasamy, A.; Herman, B.; Juliano, R. L. Mechanism of Cellular Uptake of Modified Oligodeoxynucleotides Containing Methylphosphonate Linkages. Nucleic Acids Res. 1991, 19, 5543–5550.
32. Spiller, D. G.; Tidd, D. M. The Uptake Kinetics of Chimeric Oligodeoxynucleotide Analogues in Human Leukaemia MOLT-4 Cells. Anti-Cancer Drug Des. 1992, 7, 115–129.
33. Iverson, P. L.; Zhu, S.; Meter, A.; Zon, G. Cellular Uptake and Subcellular Distribution of Phosphorothioate Oligonucleotides into Cultured Cells. Antisense Res. Dev. 1992, 2, 211–222.
34. Thierry, A. R.; Dritschillo, A. Intracellular Availability of Unmodified, Phosphorothioated and Liposomally Encapsulated Oligodeoxynucleotides for Antisense Activity. Nucleic Acids Res. 1992, 20, 5691–5698.
35. Leonetti, J. P.; Mechti, N.; Degols, G.; Gagnor, G.; Lebleu, B. Intracellular Distribution of Microinjected Antisense Oligonucleotides. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 2702–2706.
36. Chin, D. J.; Green, G. A.; Zon, G.; Szoka, F. C.; Straubinger, R. M. Rapid Nuclear Accumulation of Injected Oligodeoxyribonucleotides. New Biologist 1990, 2, 1091–1100.
37. Fisher, T. L.; Terhorst, T.; Cao, X.; Waper, R. W. Intracellular Disposition and Metabolism of Unmodified and Modified Olionucleotides Microinjected into Mammalian Cells. Nuc. Acids Res. 1993, in press.
38. Colige, A.; Sokolov, B. P.; Nugent, P.; Baserga, R.; Prockop, D. J. Use of an Antisense Oligonucleotide to Inhibit Expression of a Mutated Human Procollagen Gene (COL1A1) in Transfected Mouse 3T3 Cells. Biochemistry 1993, 32, 7–11.
39. Vickers, T.; Baker, B. F.; Cook, P. D.; Zounes, M.; Buckheit, R. W.; Germany, J.; Ecker, D. J. Inhibition of HIV-LTR Gene Expression by Oligonucleotides Targeted to the TAR Element. Nucleic Acids Res. 1991, 19, 3359–3368.
40. Monia, B. P.; Johnston, J. F.; Ecker, D. J.; Zounes, M. A.; Lima, W. F.; Freier, S. M. Selective Inhibition of Mutant Ha-ras mRNA Expression by Antisense Oligonucleotides. J. Biol. Chem. 1992, 267, 19954–19962.
41. Chiang, M. Y.; Chan, H.; Zounes, M. A.; Freier, S. M.; Lima, W. F.; Bennett, C. F. Antisense Oligonucleotides Inhibit Intercellular Adhesion Molecule 1 Expression by Two Distinct Mechanisms. J. Biol. Chem. 1991, 266, 18162–18171.
42. Miller, P. S. Oligonucleoside Methylphosphonates as Antisense Reagents. Bio/Technology 1991, 9, 358–361.
43. Tidd, D. M.; Warenius, H. M. Partial Protection of Oncogene, Anti-Sense Oligodeoxynucleotides Against Serum Nuclease Degradation Using Terminal Methylphosphonate Groups. Br. J. Cancer 1989, 60, 343–350.
44. Shaw, J. P.; Kent, K.; Bird, J.; Fishback, J.; Froehler, B. F. Modified Deoxyoligonucleotides Stable to Exonuclease Degradation in Serum. Nucleic Acids Res. 1991, 19, 747–750.
45. Hoke, G. D.; Draper, K.; Freier, S. M.; Gonzalez, C.; Driver, V. B.; Zounes, M. C.; Ecker, D. J. Effects of Phosphorothioate Capping on Antisense Oligonucleotide Stability, Hybridization and Antiviral Efficacy Versus Herpes Simplex Virus Infection. Nucleic Acids Res. 1991, 19, 5743–5748.
46. Woolf, T. M.; Jennings, C. G. B.; Rebagliati, M.; Melton, D. A. The Stability, Toxicity and Effectiveness of Unmodified Phosphorothioate Antisense Oligodeoxynucleotides in Xenopus Oocytes and Embryos. Nucleic Acids Res. 1990, 18, 1763–1769.
47. Herschlag, D. Implication of Ribozyme Kinetics for Targeting the Cleavage of Specific RNA Molecules In Vivo: More Isn't Always Better. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 6921–6925.
48. Cazenave, C.; Chevrier, M.; Thuong, N. T.; Helene, C. Rate of Degradation of [α]- and [β]-oligodeoxynucleotides in Xenopus Oocytes: Implications for Anti-Messenger Strategies. Nucleic Acids Res. 1987, 15, 10507–10521.
49. Dash, P.; Loten, I.; Knapp, M.; Kandel, E. R.; Goelet, P. Selective Elimination of mRNA in vivo: Complementary Oligodeoxynucleotides Promote RNA Degradation by an RNase H-like Activity. Proc. Natl. Acad. Sci. U.S.A. 1987, 84, 7896–7900.
50. Dagle, J. M.; Walder, J. A.; Weeks, D. L. Targeted Degradation of mRNA in Xenopus Oocytes and Embryos Directed by Modified Oligonucleotides: Studies of An2 and Cyclin in Embryogenesis. Nucleic Acids Res. 1990, 18, 4751–4757.
51. Woolf, T. M.; Melton, D. A.; Jennings, C. G. B. Specificity of Antisense Oligonucleotides In Vivo. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 7305–7309.
52. Boiziau, C.; Kurfurst, R.; Cazenave, C.; Roig, V.; Thuong, N. T.; Toulme, J.-J. Inhibition of Translation Initiation by Antisense Oligonucleotides via an RNase-H Independent Mechanism. Nucleic Acids Res. 1991, 19, 1113–1119.
53. Maher, L. J.; Dolnick, B. J. Comparative Hybrid Arrest by Tandem Antisense Oligodeoxyribonucleotides or Oligoribonucleoside Methylphosphonates in a Cell-Free System. Nucleic Acids Res. 1988, 16, 3341–3358.
54. Matsukura, M.; Zon, G.; Shinozuka, K.; Robert-Guroff, M.; Shimada, T.; Stein, C. A.; Mitsuya, H.; Wong-Stall, F.; Cohen, J. S.; Broder, S. Regulation of Viral Expression of Human Immunodeficiency Virus In Vitro by an Antisense Phosphorothioate Oligodeoxynucleotide Against rev (art/trs) in Chronically Infected Cells. Proc. Natl. Acad. Sci. U.S.A. 1989, 86, 4244–4248.
55. Matsukura, M.; Shinozuka, K.; Zon, G.; Mitsuya, H.; Reitz, M.; Cohen, J. S.; Broder, S. Phosphorothioate Analogs of Oligodeoxynucleotides: Inhibitors of Replication and Cytopathic Effects of Human Immunodeficiency Virus. Proc. Natl. Acad. Sci. U.S.A. 1987, 84, 7706–7710.
56. Stein, C. A.; Ranajit, P.; DeVico, A. L.; Mumbauer, S.; Kinstler, O.; Sarngadharan, M. G.; Letsinger, R. L. Mode of Action of 5'-Linked Cholesterol Phosphorothioate Oligodeoxynucleotides in Inhibiting Syncytia Formation and Infection by HIV-1 and HIV-2 In Vitro. Biochemistry 1991, 30, 2439–2444.
57. Stein, C. A.; Neckers, L. M.; Nair, B. C.; Mumbauer, S.; Hoke, G.; Pal, R. Phosphorothioate Oligodeoxycytidine Interferes with Binding of HIV-1 gpl20 to CD4. J. A. I. D. S. 1991, 4, 686–693.
58. +Cells. Science 1988, 240, 646–649.
59. Baba, M.; Pauwels, R.; Balzarini, J.; Arnout, J.; Desmyter, J.; DeClercq, E. Mechanism of Inhibitory Effect of Dextran Sulfate and Heparin on Replication of Human Immunodeficiency Virus In Vitro. Proc. Natl. Acad. Sci. U.S.A. 1988, 85, 6132–6136.
60. Lisziewicz, J.; Sun, D.; Klotman, M.; Agrawal, S.; Zamecnik, P.; Gallo, R. Specific Inhibition of Human Immunodeficiency Virus Type 1 Replication by Antisense Oligonucleotides: An In Vitro Model for Treatment. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 1120911213.
61. Gao, W. Y.; Jaroszewski, J. W.; Cohen, J. S.; Cheng, Y. C. Mechanisms of Inhibition of Herpes Simplex Virus Type 2 Growth by 28-mer Phosphorothioate Oligodeoxycytidine. J. Biol. Chem. 1990, 265, 20172–20178.
62. Gao, W. Y.; Hanes, R. N.; Vazquez-Padua, M. A.; Stein, C. A.; Cohen, J. S.; Cheng, Y. C. Inhibition of Herpes Simplex Virus Type 2 Growth by Phosphorothioate Oligodeoxynucleotides. Antimicrob. Agents Chemother. 1990, 34, 808–812.
63. Gao, W.; Stein, C. A.; Cohen, J. S.; Dutschman, G. E.; Cheng, Y. C. Effect of Phosphorothioate Homo-Oligodeoxynucleotides on Herpes Simplex Virus Type 2-Induced DNA Polymerase. J. Biol. Chem. 1989, 19, 11521–11526.
64. Crooke, R. M.; Hoke, G. D.; Shoemaker, J. E. E. In Vitro Toxicological Evaluation of ISIS 1082, a Phosphorothioate Oligonucleotide Inhibitor of Herpes Simplex Virus. Antimicrob. Agents Chemother. 1990, 36, 527–532.
65. Kulka, M.; Smith, C. C.; Aurelian, L.; Fishelevich, R.; Meade, K.; Miller, P.; Ts'o, P. O. P. Site Specificity of the Inhibitory Effects of Oligo(nucleoside Methylphosphonate)s Complementary to the Acceptor Splice Junction of Herpes Simplex Virus Type 1 Immediate Early mRNA 4. Proc. Natl. Acad. Sci. U.S.A. 1989, 86, 6868–6872.
66. Kulka, M.; Wachsman, M.; Miura, S.; Fishelevich, R.; Miller, P. S.; Ts'o, P. O. P.; Aurelian, L. Antiviral Effects of Oligo(nucleoside Methylphosphonate) Complementary to the Herpes Simplex Virus Type 1 Immediate Early mRNAs 4 and 5. Antiviral Res. 1993, 20, 115–130.
67. Storey, A.; Oates, D.; Banks, L.; Crawford, L.; Crook, T. Anti-Sense Phosphorothioate Oligonucleotides Have Both Specific and Nonspecific Effects on Cells Containing Human Papillomavirus Type 16. Nucleic Acids Res. 1991, 15, 4109–4114.
68. Petterson, U.; Ahola, H.; Stenlund, A.; Moreno-Lopez, J. Organization and Expression of the Papillomavirus Genomes. In The Papovaridae, Vol. 2, The Papillomavirus; Salzman, N., Howley, P., Eds.; Plenum Press, New York, 1984; pp 67–107.
69. Regelson, W. The Growth-Regulating Activity of Polyanions: A Theoretical Discussion of Their Place in the Intercellular Environment and Their Role in Cell Physiology. Adv. Cancer Res. 1968, 2, 223–303.
70. Cowsert, L. M.; Fox, M. C.; Zon, G.; Mirabelli, C. K. In Vitro Evaluation of Phosphorothioate Oligonucleotides Targeted to the E2 mRNA of Papillomavirus: Potential Treatment for Genital Warts. Antimicrob. Agents Chemother. 1993, 37, 171–177.
71. Iyer, R. P.; Uznanski, B.; Boal, J.; Strom, C.; Egan, W.; Matsukura, M.; Broder, S.; Zon, G.; Wilk, A.; Koziolkiewicz, M.; Stec, W. J. Abasie Oligodeoxyribonucleoside Phosphorothioates: Synthesis and Evaluation as Anti-HIV-1 Agents. Nucleic Acids. Res. 1990, 18, 2855–2859.
72. Egan, W.; Boal, J.; Iyer, R. P.; Storm, C.; Wilson, S. H.; Meyer, A.; Iversen, P. Abasie Oligodeoiyribonucleoside Phosphorothioates as Inhibitors of the Human Immunodeficiency Virus-1 (HIV-1): Phosphorothioate Inhibition of HIV-1 Reverse Transcriptase and Interactions with Syrian Hampster Fibroblast (V79) Cells. Nucleosides Nucleotides 1991, 10, 457–460.
73. WuDunn, D.; Spear, P. G. Initial Interaction of Herpes Simplex Virus with Cells is Binding to Heparan Sulfate. J. Virol. 1989, 63, 52–58.
74. Goren, M. B.; Vatter, A. E.; Fiscus, J. Polyanionic Agents as Inhibitors of Phagosome-Lysosome Fusion in Cultured Macrophages: Evolution of an Alternative Interpretation. J. Leukocyte Biol. 1987, 41, 111–121.
75. Kielian, M. C.; Steinman, R. M.; Cohn, Z. A. Intralysosomal Accumulation of Polyanions I. Fusion of Pinocytic and Phagocytic Vacuoles with Secondary Lysosomes. J. Cell Biol. 1982, 93, 866–874.
76. Weinberg, R. Oncogenes. Tumor Suppressor Genes, and Cell Transformation: Trying to Put it All Together, in Origins of Human Cancer, Brugge, J.; Curran, T.; Harlow, E.; McCormick, F., Eds.; Cold Spring Harbor Press, New York, 1991; pp 1–16.
77. Luscher, B.; Eisenman, R. N. New Light on Myc and Myb. Part II. Myb. Genes Develop 1991, 4, 2235–2241.
78. Shen-Ong, G. L. C. The myb Oncogene. Biochim. Biophys. Acta 1990, 1032, 39–52.
79. Gewirtz, A.; Calabretta, B. A c-myb Antisense Oligodeoxynucleotide Inhibits Normal Human Hematopoiesis in Vitro. Science 1988, 242, 1303–1306.
80. 1/S Transition in Normal Human T-Lymphocytes Requires the Nuclear Protein Encoded by c-myb. Science 1989, 245, 180–183.
81. Anfossi, G.; Gewirtz, A. M.; Calabretta, B. An Oligomer Complementary to c-myb-encoded mRNA Inhibits Proliferation of Human Myeloid Leukemia Cell Lines. Proc. Natl. Acad. Sci. U.S.A. 1989, 86, 3379–3383.
82. Heikkila, R.; Schwab, G.; Wickstrom, E.; Loke, S. L.; Pluznik, D. H.; Watt, R.; Neckers, L. M. A c-myc Antisense Oligodeoxynucleotide Inhibits Entry Into S Phase But Not Progress from Go to Gi. Nature 1987, 328, 445–449.
83. Furukawa, Y.; Piwnica-Worms, H.; Ernst, T. J.; Kanakura, Y.; Griffin, J. D. cdc2 Gene Expression at the G1 to S ransition in Human T Lymphocytes. Science 1990, 250, 805–808.
84. Calabretta, B.; Sims, R. B.; Valtieri, M.; Caraciolo, D.; Szczylik, C.; Venturelli, D.; Ratajczak, M.; Beran, M.; Gewirtz, A. M. Normal and Leukemic Hematopoietic Cells Manifest Differential Sensitivity to Inhibitory Effects of c-myb Antisense Oligodeoxynucleotides: An In Vitro Study Relevant to Bone Marrow Purging. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 2351–2355.
85. Ratajczak, M. Z.; Kant, J. A.; Luger, S. M.; Hijiya, N.; Zhang, J.; Zon, G.; Gewirtz, A. M. In Vivo Treatment of Human Leukemia in a SCID Mouse Model with c-myb Antisense Oligodeoxynucleotides. Proc. Natl. Acad. Sci. U.S.A. 1991, 89, 11823–11827.
86. Simons, M.; Rosenberg, R. D. Antisense Nonmuscle Myosin Heavy Chain and c-myb Oligonucleotides Suppress Smooth Muscle Cell Proliferation In Vitro. Circ. Res. 1992, 70, 835–943.
87. Simons, M.; Edelman, E. R.; DeKeyser, J. L.; Langer, R.; Rosenberg, R. D. Antisense c-myb Oligonucleotides Inhibit Intimai Arterial Smooth Muscle Cell Accumulation In Vivo. Nature 1992, 359, 67–70.
88. Hanke, H.; Oberhoff, M.; Hanke, S.; Hessenstein, S.; Kamenz, J.; Schmid, K. M.; Betz, E.; Karsch, K. R. Inhibition of Cellular Proliferation After Experimental Balloon Angioplasty by Low-Molecular-Weight Heparin. Circulation 1992, 4, 1548–1556.
89. Biro, S.; Fu, Y. M.; Yu, Z. X.; Epstein, S. E. Inhibitory Effects of Antisense Oligodeoxynucleotides Targeting c-myc mRNA on Smooth Muscle Cell Proliferation and Migration. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 654–658.
90. Ebbecke, M.; Unterberg, C.; Buchwald, A.; Stohr, S.; Wiegand, V. Antiproliferative Effecte of a c-myc Antisense Oligonucleotide on Human Arterial Smooth Muscle Cells. Basic Res. Cardiol. 1992, 87, 585–591.
91. Speir, E.; Epstein, S. E. Inhibition of Smooth Muscle Cell Proliferation by an Antisense Oligodeoxynucleotide Targeting the Messenger RNA Encoding Proliferating Cell Nuclear Antigen. Circulation 1992, 86, 538–547.
92. Itoh, H.; Mukoyama, M.; Pratt, R. E.; Dzau, V. J. Specific Blockade of Basic Fibroblast Growth Factor Gene Expression in Endothelial Cells by Antisense Oligonucleotide. Biochem. Biophys. Res. Commun. 1992, 188, 1205–1213.
93. Tidd, D. M.; Hawley, P.; Warenius, H. M.; Gibson, I. Evaluation of N-ras Oncogene Anti-Sense, Sense and Nonsense Sequence Methylphosphonate Oligonucleotide Analogues. Anti-Cancer Drug Des. 1988, 3, 117–127.
94. Brown, D.; Yu, Z.; Miller, P.; Blake, K.; Wei, C.; Kung, H. F.; Black, R. J.; Ts'o, P. O. P.; Chang, E. H. Modulation of ras Expression by Anti-sense Nonionic Deoxyoligonucleotide Analogs. Oncogene Res. 1989, 2, 243–252.
95. Chang, E. H.; Yu, Z.; Shinozuka, K.; Zon, G.; Wilson, W. D.; Strekowska, A. Comparative Inhibition of ras p21 Protein Synthesis with Phosphorus-Modified Antisense Oligonucleotides. Anti-Cancer Drug Des. 1989, 4, 221–232.
96. Chang, E. H.; Miller, P. S.; Cushman, C.; Devadas, K.; Pirollo, K. F.; Ts'o, P. O. P.; Yu, Z. P. Antisense Inhibition of ras p21 Expression That Is Sensitive to a Point Mutation. Biochemistry 1991, 30, 8283–8286.
97. Chrissey, L. An Indexed Bibliography of Antisense Literature, 1978-1990. Antisense Res. Dev. 1991, 1, 65–113.
98. Graessmann, M.; Michaels, G.; Berg, B.; Graessmann, A. Inhibition of SV40 Gene Expression by Microinjected Small Antisense RNA and DNA Molecules. Nucleic Acids Res. 1991, 19, 53–59.
99. Froehler, B. C.; Wadwani, S.; Terhorst, T. J.; Gerrard, S. R. Oligodeoxynucleotides Containing C-5 Propyne Analogs of 2′-Deoxyuridine and 2′-Deoxycytidine. Tetrahedron Lett. 1992, 33, 5307–5310.
100. Uhlmann, E.; Peyman, A. Antisense Oligonucleotides: A New Therapeutic Principle. Chem. Rev. 1990, 90, 544–584.
101. Cook, P. D. Medicinal Chemistry of Antisense Oligonucleotides—Future Opportunities. Anti-Cancer Drug Des. 1991, 6, 585607.
102. Kibler-Herzog, L.; Zon, G.; Uznanski, B.; Whittier, G.; Wilson, W. D. Duplex Stabilities of Phosphorothioate, Methylphosphonate and RNA Analogs of Two DNA 14-mers. Nucleic Acids Res. 1991, 19, 2979–2986.
103. Lesnikowski, Z. J.; Jaworska, M.; Stec, W. J. Octa(thymidine Methanephosphonates) of Partially Defined Stereochemistry: Synthesis and Effect of Chirality at Phosphorus on Binding to Pentadecadeoxyriboadenylic Acid. Nucleic Acids Res. 1990, 18, 2109–2115.
104. Stec, W. J.; Grajkowski, A.; Koziolkiewicz, M.; Uznanski, B. Novel Route to Oligo(deoxyribonucleoside Phosphorothioates). Stereocontrolled Synthesis of P-chiral Oligo(deoxyribonucleoside Phosphorothioates). Nucleic Acids Res. 1991, 19, 5883–5888.
105. Marshall, W. S.; Caruthers, M. Phosphorodithioate DNA as a Potential Therapeutic Drug. Science 1993, 259, 1564–1570.
106. Bjergarde, K.; Dahl, B. H.; Dahl, D. Preparation and Properties of Oligodeoxynucleoside Phosphorodithioates. Nucleosides Nucleotides. 1991, 10, 461–464.
107. Bjergarde, K.; Dahl, O. Solid Phase Synthesis of Oligodeoxyribonucleoside Phosphorodithioates from Thiophosphoramidites. Nucleic Acids. Res. 1991, 19, 5843–5850.
108. Caruthers, M. H.; Beaton, G.; Cummins, L.; Dellinger, D.; Graff, D.; Ma, Y. X.; Marshall, W. S.; Sasmor, H.; Shankland, P.; Van Wu, J.; Yau, E. K. Chemical and Biochemical Studies with Dithioate DNA. Nucleosides Nucleotides 1991, 10, 47–59.
109. Froehler, B.; Ng, P.; Matteucci, M. Phosphoramidate Analogues of DNA: Synthesis and Thermal Stability of Heteroduplexes. Nucleic Acids Res. 1988, 16, 4831–4839.
110. Agrawal, S.; Goodchild, J.; Civeira, M.; Sarin, P. S.; Zamecnik, P. C. Phosphoramidate, Phosphorothioate, and Methylphosphonate Analogs of Olgiodeoxynucleotides: Inhibitors of Replication of Human Immunodeficiency Virus. Nucleosides Nucleotides 1989, 8, 819–823.
111. Marcus-Sekura, C. J.; Woerner, A. M.; Shinozuka, K.; Zon, G.; Quinnan, G. V. Comparative Inhibition of Chloramphenicol Acetyltransferase Gene Expression by Antisense Oligonucleotide Analogues Having Alkyl Phosphotriester, Methylphosphonate and Phosphorothioate Linkages. Nuc. Acids Res. 1987, 15, 5749–5763.
112. Sood, A.; Shaw, R. B.; Spielvogel, B. F. Boron-Containing Nucleic Acids. Synthesis of Oligonucleoside Boranophosphates. J. Am. Chem. Soc. 1991, 112, 9000–9007.
113. Mag, M.; Luking, S.; Engels, J. W. Synthesis and Selective Cleavage of an Oligodeoxynucleotide Containing a Bridged Internucleotide 5′-Phosphorothioate Linkage. Nucleic Acids Res. 1991, 19, 1437–1441.
114. Vyle, J. S.; Connolly, B. A.; Kemp, D.; Casstick, R. Sequence- and Strand-Specific Cleavage in Oligodeoxyribonucleotides and DNA Containing 3'-Thiothymidine. Biochemistry 1992, 31, 3012–3018.
115. Heinemann, U.; Rudolph, L. N.; Alings, C.; Morr, M.; Heikens, W.; Frank, R.; Blocker, H. Effect of a Single 3′-Methylene Phophonate Linkage on the Conformation of an A-DNA Octamer Double Helix. Nucleic Acids Res. 1991, 19, 427–433.
116. Mag, M.; Schmidt, R.; Engels, J. W. Synthesis and Selective Cleavage of an Oligodeoxynucleotide Containing a Bridged Non-Chiral Internucleotide 3′-Phosphoramidate Linkage. Tetrahedron Lett. 1992, 33, 7323–7326.
117. Musicki, B.; Widlanski, T. S. Synthesis of Carbohydrate Sulfonates and Sulfonate Esters. J. Org. Chem. 1990, 55, 4231–4233.
118. Reynolds, R. C.; Crooks, P. A.; Maddry, J. A.; Akhtar, M. S.; Montgomery, J. A.; Secrist, J. A. Synthesis of Thymidine Dimers Containing Internucleotide Sulfonate and Sulfonamide Linkages. J. Org. Chem. 1992, 57, 2983–2985.
119. Musicki, B.; Widlanski, T. S. Synthesis of Nucleoside Sulfonates and Sulfones. Tetrahedron Lett. 1991, 32, 1267–1270.
120. Huang, Z.; Schneider, C.; Benner, S. A. Building Blocks for Oligonucleotide Analogues with Dimethylene Sulfide, Sulfoxide, and Sulfone Groups Replacing Phosphodiester Linkages. J. Org. Chem. 1991, 56, 3869–3882.
121. Schneider, K. C.; Benner, S. A. Building Blocks for Oligonucleotide Analogs with Dimethylene-Sulfide, -Sulfoxide, and -Sulfone Groups Replacing Phosphodiester Linkages. Tetrahedron Lett. 1989, 30, 335–339.
122. Huie, E. M.; Kirshenbaum, M. R.; Trainor, G. L. Oligonucleotides with a Nuclease-Resistant Sulfur-Based Linkage. J. Org. Chem. 1992, 57, 4569–4570.
123. Matteucci, M.; Lin, K. Y.; Butcher, S.; Moulds, C. Deoxyoligonucleotides Bearing Neutral Analogues of Phosphodiester Linkages Recognize Duplex DNA via Triple-Helix Formation. J. Am. Chem. Soc. 1991, 113, 7767–7768.
124. Matteucci, M. Deoxyoligonucleotide Analogs Based on Formacetal Linkages. Tetrahedron Lett. 1990, 31, 2385–2388.
125. Matteucci, M. Hybridization Properties of a Deoxyoligonucleotide Containing Four Formacetal Linkages. Nucleosides Nucleotides 1991, 10, 231–234.
126. Jones, B.; Ling, K. Y.; Milligan, J. F.; Wadwani, S.; Matteucci, M. D. Synthesis and Binding Properties of Pyrimidine Oligodeoxynucleoside Analogs Containing Neutral Phosphodiester Replacements: The Formacetal and 3′-Thioformacetal Internucleoside Linkages. J. Org. Chem. 1993, 58, 2983–2991.
127. Kawai, S. H.; Just, G. Synthesis of a Non-Hydrolyzable Dinucleoside Analogue. Nucleosides Nucleotides 1991, 10, 1485–1498.
128. Gait, M. J.; Jones, A. S.; Walker, R. T. Synthetic Analogues of Polynucleotides. Part XII. Synthesis of Thymidine Derivatives Containing a Oxyacetamido- or an Oxyformamido-Linkage Instead of a Phosphodiester Group. J. Chem. Soc. Perkin Trans 1 1974, 1684–1686.
129. Gait, M. J.; Jones, A. S.; Jones, M. D.; Shepherd, M. J.; Walker, R. T. Synthetic Analogues of Polynucleotides. Part 15. The Synthesis and Properties of Poly(5′-amino-3′-O-carboxymethyl-2′,5′-dideoxy-erythro-pentonucleoBides) Containing 3′(O)-5′(C) Acetamide Linkages. J. Chem. Soc. Perkin Trans 1 1979, 1389–1394.
130. Mungall, W. S.; Kaiser, J. K. Carbamate Analogues of Oligonucleotides. J. Org. Chem. 1977, 42, 703–706.
131. Stirchak, E. P.; Summerton, J. E.; Weiler, D. D. Uncharged Stereoregular Nucleic Acid Analogues. 1. Synthesis of a Cytosine-Containing Oligomer with Carbamate Intemucleoside Linkages. J. Org. Chem. 1987, 52, 4202–4206.
132. Coull, J. M.; Carlson, D. V.; Weith, H. L. Synthesis and Characterization of a Carbamate-Linked Oligonucleoside. Tetrahedron Lett. 1987, 28, 745–748.
133. Stirchak, E. P.; Summerton, J. E.; Weiler, D. D. Uncharged Stereoregular Nucleic Acid Analogues: 2. Morpholino Nucleoside Oligomers with Carbamate Intemucleoside Linkages. Nucleic Acids Res. 1989, 17, 6129–6141.
134. Wang, H.; Weiler, D. D. Solid Phase Synthesis of Neutral Oligonucleotide Analogues. Tetrahedron Lett. 1991, 32, 7385–7388.
135. Weiler, D. D.; Daly, D. T. Molecular Modeling of Acyclic Polyamide Oligonucleotide Analogues. J. Org. Chem. 1991, 56, 6000–6006.
136. Vasseur, J. J.; Debart, F.; Sanghvi, Y. S.; Cook, P. D. Oligonucleosides: Synthesis of a Novel Methylhydroxylamine-Linked Nucleoside Dimer and Its Incorporation into Antisense Sequences. J. Am. Chem. Soc. 1992, 114, 4006–4007.
137. Debart, F.; Vasseur, J. J.; Sanghvi, Y. S.; Cook, P. D. Intermolecular Radical C-C Bond Formation: Synthesis of a Novel Dinucleoside Linker for Non-Anionic Antisense Oligonucleotides. Tetrahedron Lett. 33, 2645–2648.
138. Debart, F.; Vasseur, J. J.; Sanghvi, Y. S.; Cook, P. D. Synthesis and Incorporation of Methyleneoxy(methylimino) Linked Thymidine Dimer into Antisense Oligonucleosides. Bioorg. Med. Chem. Lett. 1992, 2, 1479–1482.
139. Nielsen, P. E.; Egholm, M.; Berg, R. H.; Buchardt, O. Sequence-Selective Recognition of DNA by Strand Displacement with a Thymine-Substituted Polyamide. Science 1991, 254, 1497–1500.
140. Hanvey, J. C.; Peffer, N. J.; Bisi, J. E.; Thomson, S. A.; Cadilla, R.; Josey, J. A.; Ricca, D. J.; Hassman, C. F.; Bonham, M. A.; Au, K. G.; Carter, S. G.; Bruckenstein, D. A.; Boyd, A. L.; Noble, S. A.; Babiss, L. E. Antisense and Antigene Properties of Peptide Nucleic Acids. Science 1992, 258, 1481–1485.
141. Egholm, M.; Buchardt, O.; Nielsen, P. E.; Berg, R. H. Peptide Nucleic Acids (PNA). Oligonucleotide Analogues with an Achiral Peptide Backbone. J. Am. Chem. Soc. 1992, 114, 1895–1897.
142. Egholm, M.; Nielsen, P. E.; Buchardt, O.; Berg, R. Recognition of Guanine and Adenine in DNA by Cytosine and Thymine Containing Peptide Nucleic Acids (PNA). J. Am. Chem. Soc. 1992, 114, 96779678.
143. Imbach, J. L.; Rayner, B.; Morvan, F. Sugar-Modified Oligonucleotides: Synthesis, Physicochemical and Biological Properties. Nucleosides Nucleotides. 1989, 8, 627–648.
144. Debart, F.; Rayner, B.; Degols, G.; Imbach, J. L. Synthesis and Base-Pairing Properties of the Nuclease Resistant α-anomeric Dodecaribonucleotide α-[r(UCUUAACCCACA)]. Nucleic Acids Res. 1992, 20, 1193–1200.
145. Damna, M. J.; Giannaris, P. A.; Marfey, P.; Reid, L. S. Oligodeoxynucleotides Containing Unnatural L-2′-Deoxyribose. Tetrahedron Lett. 32, 2673-2576.
146. Guinosso, C. J.; Hoke, G. D.; Freier, S. M.; Martin, J. F.; Ecker, D. J.; Mirabelli, C. K.; Crooke, S. T.; Cook, P. D. Synthesis and Biophysical Evaluation of 2′-Modified Antisense Oligonucleotides. Nucleosides Nucleotides 1991, 10, 259–262.
147. Shibahara, S.; Mukai, S.; Morisawa, H.; Nakashima, H.; Kobayashi, S.; Yamamoto, N. Inhibition of Human Immunodeficiency Virus (HIV-1) Replication by Synthetic Oligo-RNA Derivatives. Nucleic Acids Res. 1989, 17, 239–252.
148. Iribarren, A. M.; Sproat, B. S.; Neuner, P.; Sulston, I.; Ryder, U.; Lamond, A. 2′-O-Alkyl Oligoribonucleotides as Antisense Probes. Proc. Natl. Acad. Sci. U.S.A. 1990, 87, 7747–7751.
149. Sproat, B. S.; Iribarren, A.; Beijer, B.; Pieles, U.; Lamond, A. I. 2'-0-Alkyloligoribonucleotides: Synthesis and Applications in Studying RNA Splicing. Nucleosides Nucleotides 1991, 10, 25–27.
150. Carmo-Fonseca, M.; Pepperkok, R.; Sproat, B. S.; Ansorge, W.; Swanson, M. S.; Lamond, A. I. In Vitro Detection of snRNP-rich Organelles in the Nuclei of Mammalian Cells. EMBO J. 1991, 7, 1863–1873.
151. Szemzo, A.; Szecsi, J.; Sagi, J.; Otvos, L. First Synthesis of Carbocyclic Oligothymidylates. Tetrahedron Lett. 1990, 31, 1463–1466.
152. Froehler, B. F.; Ricca, D. J. Triple-Helix Formation by Oligodeoxynucleotides Containing the Carbocyclic Analogs of Thymidine and 5-Methyl-2′-deoxycytidine. J. Am. Chem. Soc. 1992, 114, 8320–8322.
153. Augustyns, K.; Vandendriessche, F.; Van Aerschot, A.; Busson, R.; Urbanke, C.; Herdewijn, P. Incorporation of Hexose Nucleoside Analogues into Oligonucleotides: Synthesis, Base-Pairing Properties and Enzymatic Stability. Nucleic Acids Res. 1992, 20, 4711–4716.
154. Saenger, W. Principles of Nucleic Acid Structure; Springer-Verlag, New York, 1984; pp 126–158.
155. Schmidt, S.; Pein, C. D.; Fritz, H. J.; Cech, D. Chemical Synthesis of 2′-Deoxyoligonucleotides Containing 5-fluoro-2′-deoxycytidine. Nucleic Acids Res. 1992, 20, 2421–2426.
156. Sanghvi, Y. S.; Hoke, G. D.; Zounes, M. C.; Freier, S. M.; Martin, J. F.; Chan, H.; Acevedo, O. L.; Ecker, D. J.; Mirabelli, C. K.; Crooke, S. T.; Cook, P. D. Synthesis and Biological Evaluation of Antisense Oligonucleotides Containing Modified Pyrimidines. Nucleosides Nucleotides 1991, 10, 345–346.
157. 2A Substitution. Biochemistry 1984, 23, 6723–6732.
158. Lamm, G. M.; Blencowe, B. J.; Sproat, B. S.; Iribarren, A. M.; Ryder, U.; Lamond, A. I. Antisense Probes Containing 2-Aminoadenosine Allow Efficient Depletion of U5 snRNP from HeLa Splicing Extracts. Nucleic Acids Res. 1991, 19, 3193–3198.
159. Seela, F.; Kehne, A. Oligomers with Alternating Thymidine and 2′-Deoxytubercidin: Duplex Stabilization by a 7-Deazapurine Base. Biochemistry 1985, 24, 7556–7561.
160. Seela, F.; Driller, H. Palindromic Oligonucleotides Containing 7-Deaza-2′-Deoxyguanosine: Solid-Phase Synthesis of d[(p)-GG-AATTCC] Octamers and Recognition by the Endodeoxyri-bonuclease EcoRI. Nucleic Acids Res. 1986, 14, 2319–2332.
161. Steinman, R. M.; Mellman, I. S.; Muller, W. A.; Cohn, Z. A. Endocytosis and the Recycling of Plasma Membrane. Cell. Biol. 1983, 96, 1–27.
162. Wagner, E.; Zenke, M.; Cotten, M.; Beug, H.; Birnstiel, M. L. Transferrin-Polycation Conjugates as Carriers for DNA Uptake into Cells. Proc. Natl. Acad. Sci. U.S.A. 1990, 87, 3410–3414.
163. Wu, G. Y.; Wu, C. H. Specific Inhibition of Hepatitis B Viral Gene Expression In Vitro by Targeted Antisense Oligonucleotides. J. Biol. Chem. 1992, 267, 12436–12439.
164. Bonfils, E.; Mendes, C.; Roche, A. C.; Monsigny, M.; Midoux, P. Uptake by Macrophages of a Biotinylated Oligo-α-deoxythymidylate by Using Mannosylated Streptavidin. Bioconjugate Chem. 1992, 3, 277–284.
165. Curiel, D. T.; Agrawal, S.; Wagner, E.; Cotten Adenovirus Enhancement of Transferrin-Polylysine-Mediated Gene Delivery. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 8850–8854.
166. Stevenson, M.; Iversen, P. L. Inhibition of Human Immunodeficiency Virus Type 1-mediated Cytopathic Effects by Poly (L-lysine)-conjugated Synthetic Antisense Oligodeoxyribonucleotides. J. Gen. Virol. 1989, 70, 2673–2682.
167. Krieg, A. M.; Tonkinson, J.; Matson, S.; Zhao, Q.; Saxon, M.; Zhang, L. M.; Bhanja, U.; Yakubov, L.; Stein, C. A. Modification of Antisense Phosphodiester Oligodeoxynucleotides by a 5′ Cholesteryl Moiety Increases Cellular Association and Improves Efficacy. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 1048–1052.